Location History:
- Stratford, VT (US) (2019)
- Strafford, VT (US) (2021 - 2023)
Company Filing History:
2 out of 64 
2 out of 665 
2 out of 2 Years Active: 2019-2024
Title: Chris Bailey-Kellogg: Innovator in Antibody and Microbial Infection Solutions
Introduction
Chris Bailey-Kellogg, an inventive mind based in Strafford, Vermont, is an acclaimed inventor with a remarkable portfolio of four patents. His work largely revolves around the fields of microbial infections and antibody development, showcasing his dedication to advancing biomedical science.
Latest Patents
Among his notable contributions, two of his latest patents stand out. The first is focused on deimmunized lysostaphin and methods of use. This innovation presents compositions comprising deimmunized lysostaphin as a treatment for microbial infections in or on a subject. The second patent covers antibodies and the methods to create them. This development introduces variants of a chimeric anti-EGFR antibody, which demonstrate improved thermostabilities and higher levels of humanness while maintaining a binding affinity comparable to the parental antibody. The high-quality turnkey CoDAH designs developed through a computationally-directed approach signify a significant step forward in understanding the determinants of antibody structure and function.
Career Highlights
Chris has been affiliated with notable institutions, including Dartmouth College, where he contributed to various innovative projects in the realm of biotechnology. Additionally, he has also worked with Stealth Biologics, LLC, a company known for its cutting-edge advancements in biological solutions.
Collaborations
Collaboration is key to scientific innovation, and Chris has worked alongside distinguished colleagues such as Yoonjoo Choi and Karl Griswold. Their combined expertise in cancer research and antibody formulation has likely accelerated advancements in their respective fields.
Conclusion
In summary, Chris Bailey-Kellogg represents the spirit of innovation through his groundbreaking patents and collaborative efforts. His contributions not only enhance our understanding of antibody therapy and microbial treatment but also inspire future generations of inventors and scientists seeking to make significant impacts in the biomedical landscape.